Table 4.
Relationship between clinico-radiological parameters and Uropathy/Nephropathy
Uropathy (Freq (%) | Nephropathy (Freq (%) | |||||
---|---|---|---|---|---|---|
Variable | Yes(n=26) | No(n=88) | P-value | Yes(n=12) | No(n=102) | P-value |
Age Group | 0.370 | 0.431 | ||||
20 – 29 | 2(13.3) | 13(86.7) | 0(00.0) | 15(100.0) | ||
30 – 39 | 9(22.0) | 32(78.0) | 4(9.8) | 37(90.2) | ||
40 – 49 | 12(23.1) | 40(76.9) | 7(13.5) | 45(86.5) | ||
50 – 59 | 3(50.0) | 3(50.0) | 1(16.7) | 5(83.3) | ||
Uterine Size | 0.001* | 0.002* | ||||
10/52 to 24/52 | 7(10.3) | 61(89.7) | 2(2.9) | 66(97.1) | ||
25/52 to 39/52 | 19(41.3) | 27(58.7) | 10(21.7) | 36(78.3) | ||
Fibroid size | 0.13 | 0.015* | ||||
<5 | 23(21.3) | 85(78.7) | 09(8.3) | 99(91.7) | ||
≥ 5 | 03(50.0) | 03(50.0) | 03(50.0) | 03(50.0) |
X2= Chi Square, DF= Degree of freedom
= statistically significant